USE OF RECOMBINANT HEPATITIS B CORE PARTICLES TO DEVELOP VACCINES AGAINST INFECTIOUS PATHOGENS AND MALIGNANCIES

Details for Australian Patent Application No. 2003212985 (hide)

Owner NEW YORK UNIVERSITY MEDICAL CENTER

Inventors BIRKETT, Ashley, J.; ZAVALA, Fidel

Pub. Number AU-A-2003212985

PCT Number PCT/US03/03897

PCT Pub. Number WO2003/066833

Priority 60/354,963 08.02.02 US

Filing date 7 February 2003

Wipo publication date 2 September 2003

Event Publications

24 July 2003 Complete Application Filed

  Priority application(s): 60/354,963 08.02.02 US

25 September 2003 Application Open to Public Inspection

  Published as AU-A-2003212985

28 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003212986-Soft hand, low luster, high body carpet filaments

2003212984-APPARATUS FOR EVOKING AND RECORDING BIO-POTENTIALS